captomize limited glp 1 Consumers are warned of weight loss drug scams GLP-1 Support | Appetite support

Semaglutide is a GLP-1 receptor agonist that has revolutionized the treatment of obesity, type 2 diabetes, and metabolic disorders

Pat Gently

Our single-serve stick packs are designed for modern life

It has several functions, including enhancing insulin secretion, reducing glucagon production, and slowing gastric emptying, which all synergistically work to reduce blood glucose levels

In 2022, citing shortages of the drugs, the FDA allowed compounding pharmacies to make them but with the shortages over, the FDA stopped allowing compounding pharmacies to make tirzepatide (Mounjaro and Zepbound) in March, and semaglutide (Ozempic and Wegovy) last week